Compare AQST & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AQST | MAGN |
|---|---|---|
| Founded | 2004 | 1864 |
| Country | United States | United States |
| Employees | N/A | 8500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 504.0M | 430.0M |
| IPO Year | 2007 | N/A |
| Metric | AQST | MAGN |
|---|---|---|
| Price | $4.14 | $10.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $9.00 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.6M | 364.8K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $10.08 | $5.37 |
| Revenue Next Year | $49.60 | $3.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.38 | $7.82 |
| 52 Week High | $7.55 | $15.52 |
| Indicator | AQST | MAGN |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 49.50 |
| Support Level | $4.02 | $9.93 |
| Resistance Level | $4.38 | $11.87 |
| Average True Range (ATR) | 0.22 | 0.75 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 14.90 | 24.92 |
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.